Case Reports in Dermatology · 2022 · 13 citations · 7 references
MedicineDermatologyPharmacotherapyDermatopathologyHypersensitivityRheumatologyInflammatory DermatosesInflammatory Skin DiseasesBiologic Anti-inflammatory AgentsDermatologic DisordersDermatologic PharmacologyPsoriasis ImmunopathologyPsoriasis TherapyPsoriatic Disease
Erythrodermic psoriasis (EP) is a severe, often refractory, variant of psoriasis. Due to the high morbidity and mortality rate associated with EP and other causes of erythroderma, they are often classified as dermatologic emergencies. EP is usually a therapeutic challenge, where topical and conventional systemic therapies have yielded a less than satisfactory result in several patients. Furthermore, there are a limited number of studies evaluating other therapeutic modalities, such as biologic agents, with no clear treatment guidelines. In this case report, we present a patient who was diagnosed as a case of EP and showed an impressive response to risankizumab.
7
Alan S. Boyd, Alan Menter · Journal of the American Academy of Dermatology · 1989 · 153 citations
Erythrodermic psoriasis: pathophysiology and current treatment perspectives
Wilson Liao, Rasnik Singh, Kristina Lee et al. · Psoriasis Targets and Therapy · 2016 · 130 citations · Full text